 "Doctor who sold ketamine to actor Matthew Perry gets 2.5 years in prison")
Don't want to miss the best from Business Standard?
A doctor who pleaded guilty to selling ketamine to Matthew Perry in the weeks before the "Friends" star's overdose death has been sentenced to two and a half years in prison.
Judge Sherilyn Peace Garnett handed down the sentence plus two years of probation to 44-year-old Dr. Salvador Plasencia in a federal courtroom in Los Angeles on Wednesday.
Plasencia was the first to be sentenced of the five defendants who have pleaded guilty in connection with Perry's death at age 54 in 2023.
Plasencia admitted to illegally selling large amounts of ketamine to Perry, though he did not supply the dose that authorities say killed the actor. The doctor admitted to taking advantage of Perry, knowing he was a struggling addict. Plasencia texted another doctor that Perry was a "moron" who could be exploited for money, according to court filings.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app